|Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada|
C Sauvageau, B Duval, V Gilca, F Lavoie, M Ouakki
BMC Public Health 7 (1), 304, 2007
|Vaccination against human papillomavirus: a baseline survey of Canadian clinicians’ knowledge, attitudes and beliefs|
B Duval, V Gilca, S McNeil, S Dobson, D Money, IM Gemmill, ...
Vaccine 25 (45), 7841-7847, 2007
|Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v)|
DM Skowronski, NZ Janjua, G De Serres, D Purych, V Gilca, ...
The Journal of infectious diseases 206 (12), 1852-1861, 2012
|Cervical cancer prevention by vaccination: nurses’ knowledge, attitudes and intentions|
B Duval, V Gilca, N Boulianne, K Pielak, B Halperin, MA Simpson, ...
Journal of advanced nursing 65 (3), 499-508, 2009
|Cost-effectiveness analyses of hepatitis a vaccine|
AM Anonychuk, AC Tricco, CT Bauch, V Gilca, B Duval, A John-Baptiste, ...
Pharmacoeconomics 26 (1), 17-32, 2008
|Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country|
B Duval, V Gîlca, N Boulianne, P De Wals, R Massé, G Trudeau, ...
The Pediatric infectious disease journal 24 (3), 213-218, 2005
|Cost-utility of universal hepatitis A vaccination in Canada|
CT Bauch, AM Anonychuk, BZ Pham, V Gilca, B Duval, MD Krahn
Vaccine 25 (51), 8536-8548, 2007
|Parents’ decision-making about the human papillomavirus vaccine for their daughters: I. Quantitative results|
A Krawczyk, B Knäuper, V Gilca, E Dubé, S Perez, K Joyal-Desmarais, ...
Human vaccines & immunotherapeutics 11 (2), 322-329, 2015
|Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine|
V Gilca, G De Serres, N Boulianne, D Murphy, P De Wals, M Ouakki, ...
Vaccine 31 (3), 448-451, 2013
|Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review|
B Duval, G De Serres, V Gilca, AC Tricco, J Ochnio, DW Scheifele
BMC Infectious diseases 5 (1), 56, 2005
|Antibody persistence and response to 2010–2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children|
V Gilca, G De Serres, ME Hamelin, G Boivin, M Ouakki, N Boulianne, ...
Vaccine 30 (1), 35-41, 2011
|Determinants of parents’ decision to vaccinate their children against rotavirus: results of a longitudinal study|
E Dubé, JA Bettinger, B Halperin, R Bradet, F Lavoie, C Sauvageau, ...
Health education research 27 (6), 1069-1080, 2012
|Canadian oncogenic human papillomavirus cervical infection prevalence: Systematic review and meta-analysis|
AC Tricco, CH Ng, V Gilca, A Anonychuk, S Berliner
BMC infectious diseases 11 (1), 235, 2011
|Impact of an immunization campaign to control an increased incidence of serogroup B meningococcal disease in one region of Quebec, Canada|
P De Wals, G Deceuninck, B Lefebvre, R Tsang, D Law, G De Serres, ...
Clinical Infectious Diseases 64 (9), 1263-1267, 2017
|Canadian family physicians' and paediatricians' knowledge, attitudes and practices regarding A (H1N1) pandemic vaccine|
E Dubé, V Gilca, C Sauvageau, N Boulianne, FD Boucher, JA Bettinger, ...
BMC Research Notes 3 (1), 102, 2010
|Nationwide Canadian study of hepatitis A antibody prevalence among children eight to thirteen years old|
B Duval, G De Serres, J Ochnio, D Scheifele, V Gilca
The Pediatric infectious disease journal 24 (6), 514-519, 2005
|Cross-reactive antibody to swine influenza A (H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in …|
DM Skowronski, G De Serres, NZ Janjua, JL Gardy, V Gilca, M Dionne, ...
Eurosurveillance 17 (4), 20066, 2012
|Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: methodological challenges and initial results of a pan-Canadian longitudinal …|
S Perez, O Tatar, GK Shapiro, E Dubé, G Ogilvie, J Guichon, V Gilca, ...
BMC Public Health 16 (1), 1223, 2016
|The changing epidemiology of meningococcal disease in Quebec, Canada, 1991–2011: potential implications of emergence of new strains|
R Gilca, G Deceuninck, B Lefebvre, R Tsang, R Amini, V Gilca, ...
PloS one 7 (11), e50659, 2012
|Burden of acute otitis media on Canadian families|
E Dubé, P De Wals, V Gilca, N Boulianne, M Ouakki, F Lavoie, R Bradet
Canadian Family Physician 57 (1), 60-65, 2011